Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma (IFM 01/01)
This study has been terminated.
( survival advantage demonstrated )
Study NCT00644306
Information provided by Central Hospital, Nancy, France
First Received: March 20, 2008
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
